健世科技-B(09877)：经导管三尖瓣置换系统LuX-Valve Plus取得欧盟MDR CE认证

智通财经07-08

智通财经APP讯，健世科技-B(09877)发布公告，近日，集团自主研发的经导管三尖瓣置换系统(Transvenous Tricuspid Valve Replacement System) LuX-Valve Plus取得欧盟MDR CE认证，达成公司国际化战略的重要里程碑。LuX-Valve Plus是全球第二款获批的经导管塬位三尖瓣置换产品。其通过经血管入路进一步减小对心脏组织的损伤;采用不...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2649955634?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-08 08:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649955634","market":"hk","top_or_hot":-1,"title":"健世科技-B(09877)：经导管三尖瓣置换系统LuX-Valve Plus取得欧盟MDR CE认证","media":"智通财经","content":"<div>\n<p>智通财经APP讯，健世科技-B(09877)发布公告，近日，集团自主研发的经导管三尖瓣置换系统(Transvenous Tricuspid Valve Replacement System) LuX-Valve Plus取得欧盟MDR CE认证，达成公司国际化战略的重要里程碑。LuX-Valve Plus是全球第二款获批的经导管塬位三尖瓣置换产品。其通过经血管入路进一步减小对心脏组织的损伤;采用不...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1464458.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>健世科技-B(09877)：经导管三尖瓣置换系统LuX-Valve Plus取得欧盟MDR CE认证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n健世科技-B(09877)：经导管三尖瓣置换系统LuX-Valve Plus取得欧盟MDR CE认证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-08 08:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1464458.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，健世科技-B(09877)发布公告，近日，集团自主研发的经导管三尖瓣置换系统(Transvenous Tricuspid Valve Replacement System) LuX-Valve Plus取得欧盟MDR CE认证，达成公司国际化战略的重要里程碑。LuX-Valve Plus是全球第二款获批的经导管塬位三尖瓣置换产品。其通过经血管入路进一步减小对心脏组织的损伤;采用不...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1464458.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4109","symbol_name":"特种化学制品","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1464458.html","article_id":"2649955634","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2649955634","pubTimestamp":1783468948,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，健世科技-B 发布公告，近日，集团自主研发的经导管三尖瓣置换系统 LuX-Valve Plus取得欧盟MDR CE认证，达成公司国际化战略的重要里程碑。LuX-Valve Plus是全球第二款获批的经导管塬位三尖瓣置换产品。公司正持续快速推进LuX-Valve Plus在欧洲以及全球的商业化进程，实现公司长期国际化战略目标。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4109":"特种化学制品","BK4588":"碎股","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","PSCM":"Invesco S&P SmallCap Materials ETF","CE":"塞拉尼斯","09877":"健世科技-B"},"translate_title":"Jianshi Technology-B (09877): Transcatheter Tricuspid Valve Replacement System LuX-Valve Plus Achieves EU MDR CE Certification","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FESXmain":1.5,"PSCM":0.6,"CE":1.5,"09877":1.5,"FSXEmain":1.5},"content_text":"智通财经APP讯，健世科技-B(09877)发布公告，近日，集团自主研发的经导管三尖瓣置换系统(Transvenous Tricuspid Valve Replacement System) LuX-Valve Plus取得欧盟MDR CE认证，达成公司国际化战略的重要里程碑。LuX-Valve Plus是全球第二款获批的经导管塬位三尖瓣置换产品。其通过经血管入路进一步减小对心脏组织的损伤;采用不依赖径向支撑力的室间隔锚定设计，利于术后右心重构，有效降低起搏器植入风险;自适应防漏裙边减少术后瓣周漏;多维可调弯输送系统，利于术中瓣膜释放的精准定位;提供40mm 70mm七个尺寸型号，能够覆盖广泛未被满足的三尖瓣反流临床需求。LuX-Valve系列产品入选欧洲临床专家委员会科学建议试点(Expert Panel Scientific Advice Pilot)、获得FDA突破性器械认定(Breakthrough Device)、获选加入FDA产品全生命周期咨询计划(Total Product Life Cycle Advisory Program)，并进入NMPA创新医疗器械特别审查程序。LuX-Valve Plus已在中国、欧洲、北美等主要市场开展、完成系列临床试验，临床数据在多个国际顶级学术会议重磅发布，获得全球市场和各国专家术者的高度认可，随访结果体现了产品持续、优异的安全性和有效性，患者三尖瓣反流等级显著改善，心功能持续提高，生活品质大幅提升，并维持较低的不良事件发生率。LuX-Valve系列产品已为全球五大洲数十个国家地区的超千例患者完成临床植入，积累了丰富的应用经验，弥补了大量三尖瓣反流尤其复杂解剖结构患者的临床治疗空白。公司正持续快速推进LuX-Valve Plus在欧洲以及全球的商业化进程，实现公司长期国际化战略目标。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2649955634","isCrawlerRequest":true}